Mesmar en es it fr

Mesmar Brand names, Mesmar Analogs

Mesmar Brand Names Mixture

  • No information avaliable

Mesmar Chemical_Formula


Mesmar RX_link

No information avaliable

Mesmar fda sheet

Mesmar msds (material safety sheet)

Mesmar Synthesis Reference

No information avaliable

Mesmar Molecular Weight

309.469 g/mol

Mesmar Melting Point

< 25 oC

Mesmar H2O Solubility

Soluble as HCl salt

Mesmar State


Mesmar LogP


Mesmar Dosage Forms

Tablets (oral, 1 mg)

Mesmar Indication

Used for the symptomatic treatment of parkinsonism.

Mesmar Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Mesmar Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Mesmar side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Mesmar Patient Information

Mesmar Organisms Affected

Humans and other mammals